Published in
Elsevier, Clinical Gastroenterology and Hepatology, 2(20), p. 465-467.e2, 2022
DOI: 10.1016/j.cgh.2021.01.006
Links
Tools
Patients With Low Drug Levels or Antibodies to a Prior Anti–Tumor Necrosis Factor Are More Likely to Develop Antibodies to a Subsequent Anti–Tumor Necrosis Factor
Journal article published in 2022 by
Niels Vande Casteele,
Maria T. Abreu,
Sarah Flier,
Konstantinos Papamichael,
Florian Rieder,
Mark S. Silverberg,
Reena Khanna,
Lauren Okada 
,
Lei Yang,
Anjali Jain,
Adam S. Cheifetz
,
Lei Yang,
Anjali Jain,
Adam S. Cheifetz
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 